Breaking News, Promotions & Moves

CorePharma Under New Ownership

A group of industry investors have acquired the company and all of its facilities and equipment

A group of industry investors have announced the 100% acquisition of CorePharma in Middlesex, NJ from Impax Laboratories.    The acquisition does include all equity, equipment, and facilities, but does not include any pending or approved Abbreviated New Drug Applications (ANDAs) or currently marketed products.    Effective immediately upon closing of the deal, Arpit Patel has been appointed as the chief executive officer of CorePharma, and will also become a member of the Board o...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters